4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-031300
Chief Medical Officer sold 4,000 shares at an average $34.83 ($139,309)
- Chief Medical Officer acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Alland Leila · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-07 | Exercise or conversion : show line 1 in the form | +4,000 | $3.90 | $15,600 | 4,000 | D |
| 2021-05-07 | Sale : show line 2 in the form | −3,842 | $34.80 | $133,702 | 158 | D |
| 2021-05-07 | Sale : show line 3 in the form | −158 | $35.49 | $5,607 | 0 | D |
| Open-market sales · 4,000 sh · avg $34.83 · $139,309 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-07 | Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) | −4,000 | 369,850 | D |
Loading xslF345X03/doc4.xml…